Description
PD-L1 (Atezolizumab Biosimilar) Human mAb was confirmed to bind to its intended target protein PD-L1 using flow cytometry and bio-layer interferometry. PD-L1 (Atezolizumab Biosimilar) Human mAb is produced at Cell Signaling Technology. Atezolizumab is an antibody that is directed against the extracellular region of human PD-L1.
Target
PD-L1
Target Alias Names
CD274, PD-L1
Isotype/Mimetic
IgG1 kappa
Animal-Derived Biomaterials Used
BSA
Sequence Available
Yes
Original Discovery Method
Immunization
Antibody/Binder Origins
Animal-dependent discovery, post-2020, In vitro recombinant expression, Animal-derived biomaterials used in production or final formulation